Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Enzo Biochem's Enterprise Value is $1.24 Mil.
Enzo Biochem's EBIT for the trailing twelve months (TTM) ended in Jan. 2024 was $-4.54 Mil. Therefore, Enzo Biochem's EV-to-EBIT ratio for today is -0.27.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Enzo Biochem's Enterprise Value is $1.24 Mil.
Enzo Biochem's EBITDA for the trailing twelve months (TTM) ended in Jan. 2024 was $-2.75 Mil. Therefore, Enzo Biochem's EV-to-EBITDA ratio for today is -0.45.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Enzo Biochem's Enterprise Value is $1.24 Mil.
Enzo Biochem's Revenue for the trailing twelve months (TTM) ended in Jan. 2024 was $12.81 Mil. Therefore, Enzo Biochem's EV-to-Revenue ratio for today is 0.10.
Enzo Biochem Enterprise Value Historical Data
The historical data trend for Enzo Biochem's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Enzo Biochem's Enterprise Value
For the Diagnostics & Research subindustry, Enzo Biochem's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Enzo Biochem's Enterprise Value Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Enzo Biochem's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Enzo Biochem's Enterprise Value falls into.
Enzo Biochem Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Enzo Biochem's Enterprise Value for the fiscal year that ended in Jul. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enzo Biochem (NYSE:ENZ) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Enzo Biochem's current Enterprise Value is $1.24 Mil.
Enzo Biochem's EBIT for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-4.54 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Enzo Biochem's current Enterprise Value is $1.24 Mil.
Enzo Biochem's EBITDA for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.75 Mil.
Enzo Biochem's current Enterprise Value is $1.24 Mil.
Enzo Biochem's Revenue for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $12.81 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enzo Biochem Enterprise Value Related Terms
Thank you for viewing the detailed overview of Enzo Biochem's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. It focuses on delivering and applying its technology to produce products and services to allow its customers to meet their clinical needs. The company has Enzo clinical labs, Enzo life sciences, Enzo therapeutics operating segments. It derives the majority of its revenues from the Clinical lab's segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ENZ has been successfully added to your 